Peregrine Capital Management LLC Boosts Holdings in Azenta, Inc. (NASDAQ:AZTA)

Peregrine Capital Management LLC increased its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 53.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 149,377 shares of the company's stock after acquiring an additional 52,120 shares during the period. Peregrine Capital Management LLC owned about 0.33% of Azenta worth $7,469,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in AZTA. Farther Finance Advisors LLC boosted its position in shares of Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after buying an additional 256 shares during the last quarter. KBC Group NV raised its holdings in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after purchasing an additional 698 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in shares of Azenta during the fourth quarter valued at approximately $200,000. Net Worth Advisory Group purchased a new position in shares of Azenta during the third quarter valued at approximately $205,000. Finally, Aigen Investment Management LP purchased a new position in shares of Azenta during the third quarter valued at approximately $214,000. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Stock Performance

Shares of Azenta stock traded down $0.03 on Friday, hitting $44.75. 423,124 shares of the company's stock were exchanged, compared to its average volume of 486,505. The company has a 50-day simple moving average of $50.46 and a 200-day simple moving average of $48.18. The stock has a market capitalization of $2.05 billion, a PE ratio of -15.02 and a beta of 1.47. Azenta, Inc. has a 1 year low of $38.82 and a 1 year high of $67.77.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on AZTA shares. Needham & Company LLC raised their price target on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. Stephens restated an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. Finally, Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.